The ALS Program at Hospital for Special Surgery is a Certified Center of Excellence providing comprehensive care, treatment, and research for patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or motor neuron disease. ALS is a progressive and fatal neuromuscular disease that affects the motor neurons responsible for controlling voluntary muscle movement.
Individuals with ALS experience muscle weakness, paralysis, and ultimately, respiratory failure leading to death. The disease affects motor neurons in the brain and spinal cord, causing muscles to waste away. Despite the lack of a cure, treatments such as riluzole and edaravone have been shown to slow the progression of ALS.
The ALS Program at Hospital for Special Surgery offers in-person and telehealth care, clinical trials, and multidisciplinary teams to assist patients and their families in managing the challenges of living with ALS. With a focus on improving quality of life and prolonging survival, the program emphasizes a comprehensive approach to care and treatment for individuals with ALS.
Research is ongoing to better understand the causes of ALS, explore potential risk factors, and develop new treatment options. By participating in research studies and clinical trials, individuals with ALS can contribute to advancements in the field and help uncover potential breakthroughs in combating this devastating disease.
Stay informed about the latest developments in ALS care, treatment, and research through the ALS Program at Hospital for Special Surgery.
Attribution:
This article was summarized and republished from the original source.
Please check the original article here: https://www.hss.edu/condition-list_amyotrophic-lateral-sclerosis.asp.